Combined modality therapy for Stage III non-small cell lung carcinoma: Results of treatment and patterns of failure
β Scribed by S. Reddy; M.S. Lee; P. Bonomi; S.G. Taylor IV; E. Kaplan; Meryl Gale; L.P. Faber; W. Warren; C.F. Kittle; F.R. Hendrickson
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 885 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twiceβdaily radiotherapy (BIDRT) or onceβdaily radiotherapy (QDRT) resulted in a better outcome for patients with limitedβst
Multi-modality treatment consisting of cisplatin, VP-16, and 5-fluorouracil chemotherapy given concomitantly with external beam radiation was used to treat 64 patients with locally advanced Stage I11 non-small cell lung carcinoma. This regimen was used in a preoperative fashion for four cycles in pa